Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
复制标题
DOI:
10.1136/jnnp-2017-316605
复制
发表时间:
2018-04-01
影响因子:
11
通讯作者:
Poesen, Koen
中科院分区:
文献类型:
--
作者:
De Schaepdryver, Maxim;Jeromin, Andreas;Poesen, Koen
Objective Phosphorylated neurofilament heavy chain (pNfH) levels are elevated in cerebrospinal fluid (CSF) of patients with amyotrophic lateral sclerosis (ALS). Instead of CSF, we explored blood as an alternative source to measure pNfH in patients with ALS.Methods In this single centre retrospective study, 85 patients with ALS, 215 disease controls (DC) and 31 ALS mimics were included. Individual serum pNfH concentrations were correlated with concentrations in CSF and with several clinical parameters. The performance characteristics of pNfH in CSF and serum of patients with ALS and controls were calculated and compared using receiver operating characteristic (ROC) curves.Results CSF and serum pNfH concentrations in patients with ALS correlated well (r=0.652, p